| Survival: | ? |
| Toxicity Grade: | 4 |
| Treatments: | Chemotherapy |
| Drugs: | Eloxatin Raltitrexed |
| Country: | Italy |
| City/State/Province: | Genoa |
| Hospital: | IST Istituto Nazionale per la Ricerca sul Cancro |
| Journal: | Link |
| Date: | 11/2001 |
| Description: |
| Patients: This study involved 11 patients with inoperable malignant pleural mesothelioma. None of the patients had been administered chemotherapy before. Treatment: The treatment consisted of two chemotherapy drugs, oxaliplatin (eloxatin) and raltitrexed Toxicity: Grade 3 or 4 toxicities included gastrointestinal, diarrhea, asthenia, neurotoxicity, and transaminase elevation. Results: Overall survival was not discussed, but the median time to progression (when the cancers grew) was 16.5 weeks. Correspondence: Dr. Roberto Maisano |